155 related articles for article (PubMed ID: 15331691)
1. Retroviral capsid determinants of Fv1 NB and NR tropism.
Stevens A; Bock M; Ellis S; LeTissier P; Bishop KN; Yap MW; Taylor W; Stoye JP
J Virol; 2004 Sep; 78(18):9592-8. PubMed ID: 15331691
[TBL] [Abstract][Full Text] [Related]
2. Single amino acid changes in the murine leukemia virus capsid protein gene define the target of Fv1 resistance.
Kozak CA; Chakraborti A
Virology; 1996 Nov; 225(2):300-5. PubMed ID: 8918916
[TBL] [Abstract][Full Text] [Related]
3. Generation and characterization of a stable full-length ecotropic murine leukemia virus molecular clone that produces novel phenotypes to Fv1 restriction.
Bae EH; Park SH; Park SM; Park JW; Lim MS; Jung YT
J Microbiol Biotechnol; 2008 Apr; 18(4):799-804. PubMed ID: 18467880
[TBL] [Abstract][Full Text] [Related]
4. Complex determinants within the Moloney murine leukemia virus capsid modulate susceptibility of the virus to Fv1 and Ref1-mediated restriction.
Ulm JW; Perron M; Sodroski J; C Mulligan R
Virology; 2007 Jul; 363(2):245-55. PubMed ID: 17343889
[TBL] [Abstract][Full Text] [Related]
5. Expression levels of Fv1: effects on retroviral restriction specificities.
Li W; Yap MW; Voss V; Stoye JP
Retrovirology; 2016 Jun; 13(1):42. PubMed ID: 27342974
[TBL] [Abstract][Full Text] [Related]
6. Identification of the regions of Fv1 necessary for murine leukemia virus restriction.
Bishop KN; Bock M; Towers G; Stoye JP
J Virol; 2001 Jun; 75(11):5182-8. PubMed ID: 11333899
[TBL] [Abstract][Full Text] [Related]
7. Residues in the murine leukemia virus capsid that differentially govern resistance to mouse Fv1 and human Ref1 restrictions.
Lassaux A; Sitbon M; Battini JL
J Virol; 2005 May; 79(10):6560-4. PubMed ID: 15858043
[TBL] [Abstract][Full Text] [Related]
8. Use of a transient assay for studying the genetic determinants of Fv1 restriction.
Bock M; Bishop KN; Towers G; Stoye JP
J Virol; 2000 Aug; 74(16):7422-30. PubMed ID: 10906195
[TBL] [Abstract][Full Text] [Related]
9. Consensus structural models for the amino terminal domain of the retrovirus restriction gene Fv1 and the murine leukaemia virus capsid proteins.
Taylor WR; Stoye JP
BMC Struct Biol; 2004 Jan; 4():1. PubMed ID: 14715087
[TBL] [Abstract][Full Text] [Related]
10. Fv1-like restriction of N-tropic replication-competent murine leukaemia viruses in mCAT-1-expressing human cells.
Aagaard L; Mikkelsen JG; Warming S; Duch M; Pedersen FS
J Gen Virol; 2002 Feb; 83(Pt 2):439-442. PubMed ID: 11807237
[TBL] [Abstract][Full Text] [Related]
11. A conserved mechanism of retrovirus restriction in mammals.
Towers G; Bock M; Martin S; Takeuchi Y; Stoye JP; Danos O
Proc Natl Acad Sci U S A; 2000 Oct; 97(22):12295-9. PubMed ID: 11027299
[TBL] [Abstract][Full Text] [Related]
12. RNA sequencing provides evidence for allelism of determinants of the N-, B- or NB-tropism of murine leukemia viruses.
Rommelaere J; Donis-Keller H; Hopkins N
Cell; 1979 Jan; 16(1):43-50. PubMed ID: 217545
[TBL] [Abstract][Full Text] [Related]
13. A single amino acid change in the murine leukemia virus capsid gene responsible for the Fv1(nr) phenotype.
Jung YT; Kozak CA
J Virol; 2000 Jun; 74(11):5385-7. PubMed ID: 10799620
[TBL] [Abstract][Full Text] [Related]
14. Novel escape mutants suggest an extensive TRIM5α binding site spanning the entire outer surface of the murine leukemia virus capsid protein.
Ohkura S; Goldstone DC; Yap MW; Holden-Dye K; Taylor IA; Stoye JP
PLoS Pathog; 2011 Mar; 7(3):e1002011. PubMed ID: 21483490
[TBL] [Abstract][Full Text] [Related]
15. Capsid processing requirements for abrogation of Fv1 and Ref1 restriction.
Dodding MP; Bock M; Yap MW; Stoye JP
J Virol; 2005 Aug; 79(16):10571-7. PubMed ID: 16051849
[TBL] [Abstract][Full Text] [Related]
16. Generation and pathogenicity of an NB-tropic SL3-3 murine leukemia virus.
Thomas CY; Nuckols JD; Murphy C; Innes D
Virology; 1993 Apr; 193(2):1013-7. PubMed ID: 8384741
[TBL] [Abstract][Full Text] [Related]
17. Ordered assembly of murine leukemia virus capsid protein on lipid nanotubes directs specific binding by the restriction factor, Fv1.
Hilditch L; Matadeen R; Goldstone DC; Rosenthal PB; Taylor IA; Stoye JP
Proc Natl Acad Sci U S A; 2011 Apr; 108(14):5771-6. PubMed ID: 21436027
[TBL] [Abstract][Full Text] [Related]
18. Retroviral restriction factors Fv1 and TRIM5alpha act independently and can compete for incoming virus before reverse transcription.
Passerini LD; Keckesova Z; Towers GJ
J Virol; 2006 Mar; 80(5):2100-5. PubMed ID: 16474118
[TBL] [Abstract][Full Text] [Related]
19. Host-selected amino acid changes at the sialic acid binding pocket of the parvovirus capsid modulate cell binding affinity and determine virulence.
López-Bueno A; Rubio MP; Bryant N; McKenna R; Agbandje-McKenna M; Almendral JM
J Virol; 2006 Feb; 80(3):1563-73. PubMed ID: 16415031
[TBL] [Abstract][Full Text] [Related]
20. One base change is sufficient for host range conversion of murine leukemia virus from B to NB tropism.
Doi K; Kawana A; Iwamoto A; Yoshikura H; Odawara T
Arch Virol; 1997; 142(9):1889-94. PubMed ID: 9672647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
